| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.8 | 0.002 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |